Vivanza Biosciences Limited has appointed Mr. Hemant Amrish Parikh as an Additional Non-Executive Non-Independent Director effective June 18, 2026. The appointment is for a period of five years, subject to the approval of shareholders in the upcoming General Meeting. Mr. Parikh is a Chemical Engineer with over 30 years of experience in the pharmaceutical industry and currently serves as the Managing Director of Vivanta Industries Limited.

The Board meeting, held on June 18, 2026, also approved the appointment of M/s. Dharti Shah & Co. as the Internal Auditor for the Financial Year 2026-2027. Ms. Dharti Shah, a qualified Chartered Accountant, holds a certificate of practice since April 7, 2017. The firm's registration number is 144870W.

Board Meeting Outcomes

Vivanza Biosciences Limited has intimated BSE Limited regarding the publication of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. In accordance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published an advertisement containing the extract of these results in an English daily newspaper (Indian Express) and a Gujarati daily newspaper (Financial Express) on May 9, 2026. The intimation was signed by Jayendra Mehta, Managing Director, and confirmed that the results were approved by the Board of Directors on May 7, 2026.

Financial Performance Overview

The Board meeting held on May 7, 2026, approved the audited financial results, marking a significant turnaround in the company's performance. Vivanza Biosciences reported a standalone net profit of ₹37.50 lacs for the full fiscal year FY26, reversing the net loss of ₹69.51 lacs recorded in the previous fiscal year. Revenue from operations surged to ₹11,223.10 lacs, a substantial increase from ₹294.28 lacs in FY25. For the quarter ended March 31, 2026, the company reported a net loss of ₹26.61 lacs, an improvement compared to the net loss of ₹96.54 lacs in the same quarter of the previous year.

On a consolidated basis, the group reported a net profit of ₹39.44 lacs for FY26, compared to a net loss of ₹67.41 lacs in FY25. Consolidated revenue from operations rose to ₹11,591.06 lacs from ₹742.33 lacs in the prior year. The consolidated net loss for Q4 FY26 stood at ₹45.08 lacs, compared to a net loss of ₹99.81 lacs in the corresponding quarter of the previous year.

Regulatory Compliance

The company has ensured compliance with SEBI regulations by disseminating the financial results through newspaper publications. The results, along with the Auditor's Report, have also been posted on the company's official website. The statutory audit was carried out by SHIVAM SONI & Co., Chartered Accountants, and the Audit Report contains no observations that impact the results for the quarter or year ended March 31, 2026. The communication regarding the advertisement publication was filed with BSE Limited under Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.